会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 엘라그산을 포함하는 동맥경화증, 고지혈증 및 지방간의예방 및 치료용 조성물
    • 含有鞣制,酸性或非酸性的组合物,用于预防和治疗肠梗塞,高血压和肝脏疾病
    • KR1020010015510A
    • 2001-02-26
    • KR1020000062334
    • 2000-10-23
    • 한국과학기술연구원
    • 복성해정태숙배기환박용복최명숙문석식권용국이은숙현병화최양규이철호안병태이새봄
    • A61K31/366
    • PURPOSE: A composition containing tannin, gallic acid or ellagic acid is provided for preventing and treating arteriosclerosis, hyperlipemia and liver diseases. CONSTITUTION: When tannin, gallic acid or ellagic acid are administrated into an animal body, they prevent the deposition of macrophage-lipid complex within the inner surface of arterial duct, decrease the concentration of GOT(glutamate-oxaloacetate transaminase), GPT(glutamate-pyruvate transaminase), gammaGTP(gamma-glutamyl transpeptidase), and lipid in serum, and strongly inhibit the damage of liver cells and the progress of fatty liver. The composition contains an effective of ellagic acid displaying an anticancer activity, that is 0.1 mg to 500 mg/weight kg a day. The composition is preferably administrated into an animal body 5 times a day in a dosage of 1 mg to 100 mg/weight kg.
    • 目的:提供含有单宁,没食子酸或鞣花酸的组合物,用于预防和治疗动脉硬化,高脂血症和肝脏疾病。 构成:当将单宁,没食子酸或鞣花酸施用于动物体内时,可防止巨噬细胞 - 脂质复合物在动脉管内表面沉积,降低GOT(谷氨酸 - 草酰乙酸转氨酶)浓度,GPT(谷氨酸 - 丙酮酸转氨酶),γGTP(γ-谷氨酰转肽酶)和血清中的脂质,并且强烈地抑制肝细胞的损伤和脂肪肝的进展。 组合物含有显示抗癌活性的有效的鞣花酸,即每天0.1mg至500mg /重量kg。 组合物优选以1mg至100mg / kg kg的剂量每天施用5次。
    • 6. 发明授权
    • 신규한 페니실리움 그리세오플범 생산균주와 콜레스테롤 대사억제제의 생산
    • 空值
    • KR100264392B1
    • 2000-08-16
    • KR1019980003012
    • 1998-02-04
    • 한국과학기술연구원
    • 김영국김미경권병목정태숙김성욱최도일황인규손광희복성해
    • C12N1/20
    • PURPOSE: A microorganism, Penicillium griseofulvum, producing pyripyropene A and a method for producing cholesterol metabolism inhibitor are provided, wherein pyripyropene A inhibits the activity of cholesterol acyltransferase(ACAT) which adsorbs cholesterol into blood, and is thus used in decreasing the blood cholesterol concentration. CONSTITUTION: Penicillium griseofulvum F1959 separated from soil by Samson method produces pyripyropene A which inhibits the activity of cholesterol acyltransferase(ACAT) and its inhibition concentration IC50 is about 35 ng/ml which is calculated by the equation. The ACAT inhibitor pyripyropene A is produced by the steps of: incubating Penicillium griseofulvum F1959 in a spawn medium containing 0.5% of glucose, 0.2% of yeast extract, 0.5% of polypeptone, 0.1% of potassium phosphate and 0.05% of magnesium sulfate at 29 deg. C for 18 hours; and incubating the microorganism in a growth medium containing 2% of starch, 0.4% of soytone, 0.3% of pama media, 0.1% of potassium phosphate, 0.05% of magnesium sulfate, 0.3% of calcium carbonate and 0.2% of sodium chloride at 29 deg. C for 120 hours.
    • 目的:提供微生物青霉菌青霉菌,产生吡柔比星A和生产胆固醇代谢抑制剂的方法,其中吡哆灵A抑制胆固醇酰基转移酶(ACAT)的活性,胆固醇酰基转移酶(ACAT)将胆固醇吸附到血液中,因此用于降低血液胆固醇浓度 。 构成:通过Samson方法从土壤中分离的灰黄霉菌F1959产生抑制胆固醇酰基转移酶(ACAT)活性的白藜芦醇A,其抑制浓度IC50为约35ng / ml,其通过该方程式计算。 通过以下步骤制备ACAT抑制剂pyripyropene A:在含有0.5%葡萄糖,0.2%酵母提取物,0.5%多聚蛋白胨,0.1%磷酸钾和0.05%硫酸镁的产卵培养基中将灰黄青霉F1959温育于29℃ 度。 C 18小时; 并在29℃下将微生物培养在含有2%淀粉,0.4%大豆油,0.3%帕马培养基,0.1%磷酸钾,0.05%硫酸镁,0.3%碳酸钙和0.2%氯化钠的生长培养基中 度。 C 120小时。